Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor

Mutations producing constitutively active G-protein coupled receptors have been found in the pathophysiology of several diseases, implying that inverse agonists at the constitutively active receptors may have preferred therapeutic applications. Because of the involvement of 5-HT2A receptors in media...

Full description

Saved in:
Bibliographic Details
Main Authors: Habib Abul Muntasir (Author), Mohiuddin Ahmed Bhuiyan (Author), Masaji Ishiguro (Author), Masanobu Ozaki (Author), Takafumi Nagatomo (Author)
Format: Book
Published: Elsevier, 2006-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_89c41733033a43e4a3430afc5334d2c2
042 |a dc 
100 1 0 |a Habib Abul Muntasir  |e author 
700 1 0 |a Mohiuddin Ahmed Bhuiyan  |e author 
700 1 0 |a Masaji Ishiguro  |e author 
700 1 0 |a Masanobu Ozaki  |e author 
700 1 0 |a Takafumi Nagatomo  |e author 
245 0 0 |a Inverse Agonist Activity of Sarpogrelate, a Selective 5-HT2A-Receptor Antagonist, at the Constitutively Active Human 5-HT2A Receptor 
260 |b Elsevier,   |c 2006-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.FP0060610 
520 |a Mutations producing constitutively active G-protein coupled receptors have been found in the pathophysiology of several diseases, implying that inverse agonists at the constitutively active receptors may have preferred therapeutic applications. Because of the involvement of 5-HT2A receptors in mediating many cardiovascular diseases, constitutively active mutants of the 5-HT2A receptor may be responsible for the disease states. Thus, the purpose of the present study was to investigate the inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, and its active metabolite, M-1; and we compared their activities with those of other 5-HT2A-receptor antagonists such as ritanserin, ketanserin, and cyproheptadine. Using a constitutively active mutant (C322K) of the human 5-HT2A receptor, we demonstrated that like other 5-HT2A-receptor antagonists, sarpogrelate acts as a potent inverse agonist by significantly reducing basal inositol phosphate levels. However, there were no significant differences between sarpogrelate and other 5-HT2A-receptor antagonists for their inverse agonist activity. Compared with the wild type receptor, mutant receptor displayed significantly higher affinity for 5-HT and lower affinity for sarpogrelate. These results indicate that stabilization of the inactive conformation of the 5-HT2A receptor may be a key component of the mechanism of action of sarpogrelate. Keywords:: 5-HT2A receptor, sarpogrelate, mutant, constitutive activity, inverse agonist 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 102, Iss 2, Pp 189-195 (2006) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319343932 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/89c41733033a43e4a3430afc5334d2c2  |z Connect to this object online.